<- Go Home

Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company’s platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.

Market Cap

$34.7M

Volume

39.2K

Cash and Equivalents

$56.4M

EBITDA

-$59.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$22.1M

Profit Margin

36.71%

52 Week High

$12.96

52 Week Low

$3.73

Dividend

N/A

Price / Book Value

0.66

Price / Earnings

-0.27

Price / Tangible Book Value

0.66

Enterprise Value

-$21.2M

Enterprise Value / EBITDA

0.35

Operating Income

-$60.1M

Return on Equity

118.52%

Return on Assets

-28.31

Cash and Short Term Investments

$56.4M

Debt

$581.0K

Equity

$51.7M

Revenue

$60.3M

Unlevered FCF

-$48.1M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches